These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 8336402)

  • 1. How long can continuous ambulatory peritoneal dialysis be continued?
    Okada K; Takahashi S; Higuchi T; Kinoshita Y; Kikuchi F; Yamauchi T; Yanai M; Kuno T; Nagura Y
    Nihon Jinzo Gakkai Shi; 1993 Jan; 35(1):65-71. PubMed ID: 8336402
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of dialysis duration and glucose absorption on nutritional indices in stable continuous ambulatory peritoneal dialysis patients.
    Pajek J; Gucek A; Kveder R; Bucar-Pajek M; Kaplan-Pavlovcic S; Bren AF
    J Ren Nutr; 2008 Nov; 18(6):503-8. PubMed ID: 18940653
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peritoneal transport status influence on atherosclerosis/inflammation in CAPD patients.
    Sezer S; Tutal E; Arat Z; Akçay A; Celik H; Ozdemir FN; Haberal M
    J Ren Nutr; 2005 Oct; 15(4):427-34. PubMed ID: 16198934
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Type III procollagen N-peptide and hyaluronate in serum and dialysate of CAPD patients].
    Wakabayashi Y; Yamada K; Miura Y; Nakano H; Nishimura M; Tsuchida H; Shigematsu T; Kawaguchi Y; Sakai O
    Nihon Jinzo Gakkai Shi; 1997 May; 39(4):408-13. PubMed ID: 9198363
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Prognosis and changes of peritoneal function in CAPD and APD patients].
    Yokoyama K
    Nihon Jinzo Gakkai Shi; 1994 Mar; 36(3):259-70. PubMed ID: 8196223
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Residual renal function in children treated with continuous ambulatory peritoneal dialysis or automated peritoneal dialysis--a preliminary study.
    Roszkowska-Blaim M; Skrzypczyk P; Drozdz D; Pietrzyk JA
    Adv Perit Dial; 2009; 25():103-9. PubMed ID: 19886329
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factors affecting low values of serum albumin in CAPD patients.
    Han DS; Lee SW; Kang SW; Choi KH; Lee HY; Cho EY; Lee JH
    Adv Perit Dial; 1996; 12():288-92. PubMed ID: 8865921
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term follow-up of body size indices, residual renal function, and peritoneal transport characteristics in continuous ambulatory peritoneal dialysis.
    Twardowski ZJ; Moore HL; Prowant BF; Satalowich R
    Adv Perit Dial; 2009; 25():155-64. PubMed ID: 19886338
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Continuous ambulatory peritoneal dialysis with a high flux membrane. A preliminary report.
    Nolph KD; Moore HL; Prowant B; Twardowski ZJ; Khanna R; Gamboa S; Keshaviah P
    ASAIO J; 1993; 39(3):M566-8. PubMed ID: 8268600
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aluminum concentrations in serum, dialysate, urine and bone among patients undergoing continuous ambulatory peritoneal dialysis (CAPD).
    Joffe P; Olsen F; Heaf JG; Gammelgaard B; Pödenphant J
    Clin Nephrol; 1989 Sep; 32(3):133-8. PubMed ID: 2791364
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The effect of the number of peritonitis episodes on peritoneal membrane function].
    Jovanović D; Nesić V; Dimitrijević Z
    Srp Arh Celok Lek; 1999; 127(1-2):28-31. PubMed ID: 10377837
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The alteration of dialysate cancer antigen 125 concentration under a biocompatible bicarbonate peritoneal dialysis solution and the preservation of the mesothelial cell viability.
    Theodoridis M; Passadakis P; Kriki P; Gioka T; Panagoutsos S; Mourvati E; Thodis E; Kantartzi K; Vargemezis V
    Ren Fail; 2008; 30(2):161-7. PubMed ID: 18300115
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical assessment of CAPD (continuous ambulatory peritoneal dialysis) for chronic end-stage renal failure].
    Ohira S; Abe K; Kon T
    Hokkaido Igaku Zasshi; 1984 Jul; 59(4):478-87. PubMed ID: 6386640
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clearance of osteocalcin in adults with end-stage renal disease undergoing CAPD.
    Klein JR; Grunewald RW; Steffgen J; Franz HE
    Adv Perit Dial; 1991; 7():225-9. PubMed ID: 1680431
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional deterioration of the peritoneum: does it occur in the absence of peritonitis?
    Ota K; Mineshima M; Watanabe N; Naganuma S
    Nephrol Dial Transplant; 1987; 2(1):30-3. PubMed ID: 3110694
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ultrafiltration failure and dialysate glucose in CAPD.
    Stegmayr B; Granbom L; Karlsson UM; Lindqvist B
    Adv Perit Dial; 1993; 9():62-4. PubMed ID: 8105964
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differences in fluid and solute transport between diabetic and nondiabetic patients at the onset of CAPD.
    Serlie MJ; Struijk DG; de Blok K; Krediet RT
    Adv Perit Dial; 1997; 13():29-32. PubMed ID: 9360646
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of dialysate volume on ultrafiltration in young patients treated with CAPD.
    Kohaut EC
    Int J Pediatr Nephrol; 1986; 7(1):13-6. PubMed ID: 3957556
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Continuous ambulatory peritoneal dialysis (CRPD)--an initial Indian experience.
    Singh NP; Gupta S; Chandra J; Anuradha S; Kohli R; Rizvi SN
    J Indian Med Assoc; 2005 Jan; 103(1):22, 24, 26 passim. PubMed ID: 16008326
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High flux peritoneal membrane is a risk factor in survival of CAPD treatment.
    Wu CH; Huang CC; Huang JY; Wu MS; Leu ML
    Adv Perit Dial; 1996; 12():105-9. PubMed ID: 8865883
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.